Cryo-Cell International, Inc. revenue by segment CCEL

Annual Quarterly

Cryo-Cell International, Inc. splits its revenue into 3 lines in its filings. The largest line in Q3 of fiscal 2026, the quarter ended Aug 31, 2026 was Umbilical Cord Blood And Cord Tissue Stem Cell Service at $7.7 million, 98% of the total.

USD in millions. The percent under a figure is the change from the same quarter a year earlier.

Line	TTM Aug 31, 2026	Q3 FY2026 Aug 31, 2026	Q2 FY2026 May 31, 2026	Q1 FY2026 Feb 28, 2026	Q4 FY2025 Nov 30, 2025	Q3 FY2025 Aug 31, 2025	Q2 FY2025 May 31, 2025	Q1 FY2025 Feb 28, 2025	Q4 FY2024 Nov 30, 2024
Revenue	31	8	8	8	8	8	8	8	8
Umbilical Cord Blood And Cord Tissue Stem Cell Service	31 -1.8% share 99.1%	8 -2.2% share 97.8%	8 -2.0% share 99.2%	8 -2.8% share 99.5%	8 -0.1% share 99.8%	8 share 99.9%	8 share 99.3%	8 share 98.7%	8 share 97.6%
Public Cord Blood Banking	0 -36.7% share 0.6%	0 +3177.5% share 1.7%	0 +8.9% share 0.6%	0 -98.3% share 0.0%	0 -99.6% share 0.0%	0 share 0.1%	0 share 0.5%	0 share 1.0%	0 share 2.0%
Prepacytecb	0 +71.4% share 0.4%	0 +8827.1% share 0.5%	0 -1.8% share 0.2%	0 +84.5% share 0.5%	0 -35.5% share 0.2%	0 share 0.0%	0 share 0.2%	0 share 0.3%	0 share 0.4%

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Services-Misc Health & Allied Services, NEC (SIC 8090)
Listed as: CCEL (NYSE)
Fiscal year ends: November 30
Incorporated in: DE
Headquarters: Oldsmar, FL
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 862692
Former names: CRYO CELL INTERNATIONAL INC (until Oct 28, 2026)

Other Services-Misc Health & Allied Services, NEC companies

All 15 Services-Misc Health & Allied Services, NEC companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.